- La ciencia nuestra de cada día, II: 2 (La Ciencia Para Todos) (Spanish Edition);
- Account Options!
- Exploring Money Laundering Vulnerabilities Through Emerging Cyberspace Technologies: A Caribbean-based Exercise.
- What is Kobo Super Points?.
- The Kindness Curriculum: Stop Bullying Before It Starts (NONE).
In some cases, doctors can use pharmacogenomic knowledge as one of the tools for practicing precision medicine. By knowing how someone's genes might affect how the body will handle or respond to a particular drug, a health care provider might change the type or amount of medicine given. This may lead to a better health outcome or make dangerous side effects less likely.
Differences in someone's genes or "pharmacogenome" can affect how the person responds to a drug in a number of ways:. Use of pharmacogenomic information to select a drug or dose of drug in the clinical setting is progressing rapidly and is available mostly in large metropolitan medical centers. This requires testing a tumor sample. These changes influence how effective and safe a drug is for a person. For example, a person's body may process a medicine more quickly than others. This means the person would require a higher dose for the drug to be effective.
The drug would then stay in the bloodstream longer.
And this may cause more severe side effects. People with colorectal cancer sometimes have a specific altered gene. These people may have serious side effects when treated with the drug irinotecan Camptosar. The altered gene makes it harder for the body to break down the drug.
Doctors prescribe lower doses of the medicine for these people to reduce side effects. Personalized medicine for cancer treatment is still under development. Researchers want to learn more about:. Talk with your health care team to find out if your treatment plan will include personalized medicine.
Request Permissions. What Is Personalized Cancer Medicine? Approved by the Cancer. Creating a personalized cancer screening and treatment plan involves: Identifying the chances of a person developing cancer and selecting screening strategies to lower the risk Matching people with treatments that may be more effective and cause fewer side effects Predicting the risk of recurrence, which is the return of cancer How personalized medicine is different Before personalized medicine, most people with a specific type and stage of cancer received the same treatment.
Vande Woude. Molecular Pathogenesis of Colorectal Cancer. Kevin M. Advances in Cancer Stem Cell Biology. Roberto Scatena. Targeted Cancer Immune Therapy. Joseph Lustgarten. Therapeutic Strategies in Cancer Biology and Pathology. Gajanan V. Multiple Sclerosis. Sandra Amor. Clinically Relevant Resistance in Cancer Chemotherapy. Borje Andersson. Federico Innocenti. Anticancer Genes. Stefan Grimm. Kim Brosen. Ming D. Nicola Brunetti-Pierri. Current Challenges in Personalized Cancer Medicine. Keiran Smalley. Sadegh Babashah.
Pharmacogenetics: Making cancer treatment safer and more effective
Cancer Genome and Tumor Microenvironment. Andrei Thomas-Tikhonenko. Godfrey Grech. Novel Biomarkers in the Continuum of Breast Cancer. Vered Stearns. Emerson C.
Benjamin Bonavida. Pharmacogenomics in Clinical Therapeutics.
Loralie J. Yusuke Nakamura. Klas G. Arterial Chemoreceptors in Physiology and Pathophysiology. Chris Peers. Epigenetic Therapy of Cancer. Genetics of Diabetes Mellitus. William L. Lowe Jr. Next Generation Sequencing and Sequence Assembly. Ali Masoudi-Nejad. Leukemia: Advances in Research and Treatment. Emil J. George C. Ocular Blood Flow. Jeffrey Kiel. Histone Deacetylases: the Biology and Clinical Implication.
Pharmacogenetics: Making cancer treatment safer and more effective - Google книги
Tso-Pang Yao. Vitaly A. Pharmacogenomic Testing in Current Clinical Practice. Alan H. Molecular mechanisms and physiology of disease.
Nilanjana Maulik. Heparin - A Century of Progress. Clive P. Chronic Lymphocytic Leukemia. Prabhjot Kaur. Antibody-Drug Conjugates and Immunotoxins. Gail Lewis Phillips. Phosphoinositides I: Enzymes of Synthesis and Degradation. Tamas Balla. Cancer Stem Cells in Solid Tumors. Alison L. Ena Ray Banerjee. Handbook of Modern Pharmaceutical Analysis.